Business Wire

  1. ExThera Medical Receives CE Mark Approval For The Seraph 100 Blood Filter
    8/6/2019

    ExThera Medical Corporation (ExThera) announced recently that it has received CE Mark approval for its Seraph 100 Microbind® Affinity Blood Filter (Seraph 100) for the reduction of pathogens during bloodstream infections (BSI)

  2. PerkinElmer Launches EUROIMMUN ELISA For Detection Of Aspergillus Infections
    8/5/2019

    PerkinElmer, Inc., a global leader committed to innovating for a healthier world, recently announced the launch of the new EUROIMMUN Aspergillus Antigen ELISA

  3. Genomind Expands Mental Health Genetic Testing Services With New Genomind Professional PGx Express
    8/5/2019

    Genomind, a leading mental health care company, is launching on August 10, 2019 Genomind Professional PGx Express, a new, more focused report and set of services to enhance its mental health genetic test

  4. Wisconsin State Laboratory Adopts Quantabio Products To Improve Newborn Screening For Spinal Muscular Atrophy And Severe Combined Immunodeficiency
    8/5/2019

    Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, recently announced the Wisconsin State Laboratory of Hygiene has adopted its technology to improve newborn screening for Spinal Muscular Atrophy (SMA) and Severe Combined Immunodeficiency (SCID)

  5. MBio Diagnostics Announces Two Contracts For Sepsis Test Development
    8/1/2019

    MBio Diagnostics, Inc., today announced two new contracts for sepsis test development. The first is a Phase II Small Business Innovative Research grant from the National Institutes of Health (NIH) focused on point-of-care implementation of the pediatric sepsis mortality risk algorithm developed at the Cincinnati Children’s Hospital Medical Center (CCHMC). The second is from The Henry M. Jackson Foundation, Inc. (HJF) for the Advancement of Military Medicine for development of a field-forward 10-plex immunoassay

  6. Modulim Granted CPT Code From The American Medical Association For Its Noninvasive Microvascular Assessment Technology
    7/30/2019

    Modulim, the global leader in noninvasive microvascular assessment using spatial frequency domain imaging (SFDI), has announced that the American Medical Association (AMA) has granted a Current Procedural Terminology (CPT) Proprietary Laboratory Analyses (PLA) Code (0061U) for the transcutaneous measurement of tissue oxygenation and hemoglobin using SFDI

  7. LabTwin Partners With CA-Based Biotech Shared Laboratory Community And Incubator; Bonneville Labs And Lab Launch Give Biotech Startups Access To World’s First Voice And AI-Powered Digital Lab Assistant
    7/30/2019

    LabTwin GmbH, the world's first voice and AI-powered digital lab assistant, recently announced partnerships with CA-based life science shared lab facilities Bonneville Labs and Lab Launch

  8. InterSystems And Rhodes Group Streamline Mobile Specimen Collection And Labeling Procedures
    7/22/2019

    InterSystems, a global leader in health information technology, and Rhodes Group, a specialized laboratory software company, announced the launch of eMyLabCollect, a cloud-based application built to streamline specimen collecting, tracking, and labeling and to automate laboratory receiving and processing procedures

  9. LabCorp Expands Consumer-Initiated Test Offering
    7/22/2019

    LabCorp, a leading global life sciences company, recently announced a significant expansion to its Pixel by LabCorp platform

  10. Study Investigates The Ability Of Continuous Noninvasive Hemoglobin Monitoring With Masimo SpHb To Reflect Acute Hemodilution During Incremental Fluid Administration
    7/22/2019

    Masimo announced recently that in a study recently published in Anesthesia & Analgesia, researchers evaluated the ability of noninvasive and continuous hemoglobin monitoring with Masimo SpHb to detect the development of acute hemodilution after graded fluid administration, by comparing it to invasively measured laboratory hemoglobin (BHb), on patients undergoing major surgery